Found 5 matching trials
Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT
N/AThis multicenter retrospective study evaluated consecutive patients with la...
Location
The Second Affiliated Hospital of Guangzhou Medical University
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT
PHASE2This study is conducted to evaluate the efficacy and safety of lenvatinib p...
Location
The Second Affiliated Hospital of Guangzhou Medical University
Combined DEB-TACE, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma
PHASE2This is an open-label, single-arm, phase 2 study. The purpose of study is t...
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
DEB-TACE, Lenvatinib and Anti-PD(L)1 Antibody as Conversion Therapy for Intrahepatic Cholangiocarcinoma
N/AThe aim of this study is to the efficacy, prognosis, adverse effects, and f...
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT
PHASE3This study is conducted to evaluate the efficacy and safety of lenvatinib p...
Location
The Second Affiliated Hospital of Guangzhou Medical University